Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Ph-Triggered Intracellular Release of Doxorubicin by a Poly(Glycidyl Methacrylate)-Based Double-Shell Magnetic Nanocarrier Publisher Pubmed



Zohreh N1 ; Rastegaran Z1 ; Hosseini SH2 ; Akhlaghi M3 ; Istrate C4 ; Busuioc C5
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Chemistry, Faculty of Science, University of Qom, P. O. Box: 37185-359, Qom, Iran
  2. 2. Department of Chemical Engineering, University of Science and Technology of Mazandaran, Behshahr, Iran
  3. 3. Research Center for Nuclear Medicine, Tehran University of Medical Sciences, Tehran, 1414713135, Iran
  4. 4. Laboratory of Atomic Structures and Defects in Advanced Materials, National Institute of Materials Physics, Magurele, Romania
  5. 5. Department of Science and Engineering of Oxide Materials and Nanomaterials, University Politehnica of Bucharest, Bucharest, Romania

Source: Materials Science and Engineering C Published:2021


Abstract

Two core-double-shell pH-sensitive nanocarriers were fabricated using Fe3O4 as magnetic core, poly(glycidyl methacrylate-PEG) and salep dialdehyde as the first and the second shell, and doxorubicin as the hydrophobic anticancer drug. Two nanocarriers were different in the drug loading steps. The interaction between the first and the second shell assumed to be pH-sensitive via acetal cross linkages. The structure of nanocarriers, organic shell loading, magnetic responsibility, morphology, size, dispersibility, and drug loading content were investigated by IR, NMR, TG, VSM, XRD, DLS, HRTEM and UV–Vis analyses. The long-term drug release profiles of both nanocarriers showed that the drug loading before cross-linking between the first and second shell led to a more pH-sensitive nanocarrier exhibiting higher control on DOX release. Cellular toxicity assay (MTT) showed that DOX-free nanocarrier is biocompatible having cell viability greater than 80% for HEK-293 and MCF-7 cell lines. Besides, high cytotoxic effect observed for drug-loaded nanocarrier on MCF-7 cancer cells. Cellular uptake analysis showed that the nanocarrier is able to transport DOX into the cytoplasm and perinuclear regions of MCF-7 cells. In vitro hemolysis and coagulation assays demonstrated high blood compatibility of nanocarrier. The results also suggested that low concentration of nanocarrier have a great potential as a contrast agent in magnetic resonance imaging (MRI). © 2020